ECTE Financial Facts

Net loss: -3.5M
Loss from operations: -3.12M
See Full Income Statement

Common stock: -698.49K
Computer equipment: -606.37K
See Full Balance Sheet

Echo Therapeutics (ECTE) Earnings

  |   Expand Research on ECTE
Next EPS Date 5/13/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -1.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -3.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/27/14 Q413 -$0.36-$0.40 +$0.04N/A$20K N/A +2.6% Details
8/8/13 Q213 -$0.51-$0.81 +$0.30$22.56M$10M N/A +13.5% Details
5/10/13 Q113 -$0.13-$0.10 -$0.03N/A$10K N/A 0% Details
11/8/12 Q312 -$0.11-$0.09 -$0.02$30.9K$40K N/A +128.6% Details
8/10/12 Q212 -$0.08-$0.07 -$0.01$30.9K$190K N/A +107.8% Details
5/11/12 Q112 -$0.08-$0.07 -$0.01$30.93K$80K N/A +71.1% Details
11/8/11 Q311 -$0.04-$0.05 +$0.01N/A$360K N/A +19.9% Details
11/8/11 Q311 -$0.04N/A N/A N/AN/A N/A +19.9% Details